Pepticom
PrivateLast Round
Series A
Extension
Jan 7, 2025
Total Funding Raised
$14.2M
Momentum Score
25 /100
Company Overview
Pepticom is a biotechnology and artificial intelligence company that has developed a drug discovery platform designed to accelerate and optimize peptide-based therapeutic development.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, ML Platforms
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pepticom Comps
Public and private peers based on sector, stage, and business model.
Pepticom Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Jan 7, 2025 | ||||
| Strategic | Mar 9, 2021 | ||||
| Series A | Oct 24, 2019 |
Key People
Founding team and executive leadership
Pepticom Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Japan Israel High Tech Ventures 2 LP | Series A Extension |
| Chartered Group | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 7, 2025
$7M round raised to extend Series A.
Pepticom Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Pepticom's valuation, stock price, and market status.
